LUPIN
LUPIN stock
LUPIN is in a mixed news setup around Pharmaceuticals; 4 recent stories are active but the saved quote move at +0.00% keeps the read balanced.
LUPIN stock
LUPIN is in a mixed news setup around Pharmaceuticals; 4 recent stories are active but the saved quote move at +0.00% keeps the read balanced.
LUPIN has built a mixed coverage cluster in the last 20 days. The strongest recurring theme is Pharmaceuticals, while the current weighted impact score is +13 from 2 bullish, 1 bearish, and 1 neutral stories across 2 sources.
LUPIN is last saved at ₹1,936 with a day move of +0.00%. That quote should be read with the article tape: a positive headline only matters if price, volume, and follow-through confirm it; a negative headline matters more when it keeps repeating across multiple publishers.
Lupin's latest financial report shows the company made Rs 5767.71 crore in sales and a profit of Rs 858.86 crore. This filing is on record. These numbers tell us how much money the company earned and how much profit it kept, which is important for understanding its financial health. This hub keeps the permanent stock view separate from short-lived article pages, so search engines and users get one accumulated view instead of scattered programmatic summaries.
Mint · 11 days ago · 2 min read
Economic Times · 13 days ago · 2 min read
Economic Times · 23 days ago · 2 min read
Economic Times · 19 Sept 2026 · 2 min read
Mint · 6 Sept 2026 · 2 min read
How LUPIN stacks against related names in this news cluster
LUPIN has appeared across 4 recent stories from 2 sources, which usually means there is a real flow of fresh headlines rather than a single isolated mention.
LUPIN coverage is currently leaning bullish, with 2 bullish, 1 bearish, and 1 neutral analyzed stories in the recent window.
Recent LUPIN coverage is clustering around Pharmaceuticals and Diagnostics. Related names showing up alongside LUPIN include CIPLA, ACUTAAS, IPCALAB.
Use this page as a coverage hub for LUPIN: start with the latest headlines, then check the dominant themes, related names, and saved market context before you form a trade or watchlist view.
3 recent mentions linked to LUPIN
TopicDiagnostics1 recent mentions linked to LUPIN
StockCIPLARelated news cluster with 2 links
Latest storyMixed Pharma Q2: Acutaas, Mankind, Ipca Labs Favored; DRL, CiplaPharma sector performance is influenced by currency, input costs, and regulatory environment. Q2 res
How retail crowds and channels are talking about LUPIN right now — context for your own research, not a trade call.